UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D. C. 20549
____________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act Of 1934
December
13, 2007
Date
of
Report (Date of earliest event reported)
___________________________________________________________________
ACURA
PHARMACEUTICALS, INC.
(Exact
Name of Registrant as Specified in Charter)
___________________________________________________________________
|
State
of New York
|
1-10113
|
11-0853640
|
|
(State
of Other Jurisdiction
|
(Commission
File Number)
|
(I.R.S.
Employer
|
|
of
Incorporation)
|
Identification
Number)
|
616
N. North Court, Suite 120
Palatine,
Illinois 60067
(Address
of principal executive offices) (Zip Code)
(847)
705-7709
(Registrant’s
telephone number, including area code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o› Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o› Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
o› Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17CFR240.14d-2(b))
o› Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR
240.13e- 4(c))
Item
5.02 Departure
of Directors or Principal Officers, Election of Directors,
Appointment
of Certain Officers; Compensatory Arrangements of Certain Officers.
(e)
On
December 13, 2007, the Registrant awarded cash bonuses to, and effective January
1, 2008, increased the annual salaries of, the named executive officers listed
below, in the amounts set forth below:
|
Name
|
Title
|
Annual
Salary
|
Bonus
Awarded
|
|
Andrew
D,. Reddick
|
President
and Chief Executive Officer
|
$365,000
(increased from $300,000)
|
$850,000
|
|
Ron
J. Spivey
|
Senior
Vice President and Chief Scientific Officer
|
$315,000
(increased from $260,000)
|
$650,000
|
|
Peter
A. Clemens
|
Senior
Vice President and Chief Financial Officer
|
$205,000
(increased from $180,000)
|
$180,000
|
|
James
F. Emigh
|
Vice
President Marketing and Administration
|
$160,000
(increased from $140,000)
|
$140,000
|
|
Robert
A. Seiser
|
Vice
President, Controller and Treasurer
|
$160,000
(increased from $133,000)
|
$140,000
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
| |
|
|
|
|
By: | /s/ Peter A. Clemens |
|
Peter
A. Clemens
|
||
| Senior Vice President & Chief Financial Officer | ||
|
Date: December
17, 2007
|
||